Literature DB >> 21155002

Toll-like receptor 9 gene mutations and polymorphisms in Japanese ulcerative colitis patients.

Kaori Fuse1, Kyoko Katakura, Natsumi Sakamoto, Hiromasa Ohira.   

Abstract

AIM: To investigated gene mutations and polymorphisms of TLR9 in Japanese ulcerative colitis (UC) patients.
METHODS: Three single nucleotide polymorphisms (SNPs) in TLR9 were identified in healthy controls, and were assessed in 48 UC patients and 47 healthy controls. Control subjects were matched for age, sex and date of blood sampling from among a subgroup of participants.
RESULTS: TLR9 -1486CC, 1174GG and 2848AA increase the risk of UC [odds ratio (OR) 2.64, 95% confidence interval (95% CI): 1.73-6.53, P = 0.042], and TLR9 -1486TT, 1174AA and 2848GG decrease the risk of UC (OR 0.30, 95% CI: 0.10-0.94, P = 0.039), although there were no correlations between SNPs and disease phenotype or TLR9 mRNA expression.
CONCLUSION: TLR9 polymorphisms are associated with increased susceptibility to UC.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21155002      PMCID: PMC3001972          DOI: 10.3748/wjg.v16.i46.5815

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  28 in total

1.  A Toll-like receptor recognizes bacterial DNA.

Authors:  H Hemmi; O Takeuchi; T Kawai; T Kaisho; S Sato; H Sanjo; M Matsumoto; K Hoshino; H Wagner; K Takeda; S Akira
Journal:  Nature       Date:  2000-12-07       Impact factor: 49.962

Review 2.  Toll meets bacterial CpG-DNA.

Authors:  H Wagner
Journal:  Immunity       Date:  2001-05       Impact factor: 31.745

Review 3.  Toll-like receptors in the induction of the innate immune response.

Authors:  A Aderem; R J Ulevitch
Journal:  Nature       Date:  2000-08-17       Impact factor: 49.962

Review 4.  Inferences, questions and possibilities in Toll-like receptor signalling.

Authors:  Bruce Beutler
Journal:  Nature       Date:  2004-07-08       Impact factor: 49.962

5.  Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis.

Authors:  Seth Rakoff-Nahoum; Justin Paglino; Fatima Eslami-Varzaneh; Stephen Edberg; Ruslan Medzhitov
Journal:  Cell       Date:  2004-07-23       Impact factor: 41.582

Review 6.  Animal models of mucosal inflammation and their relation to human inflammatory bowel disease.

Authors:  R S Blumberg; L J Saubermann; W Strober
Journal:  Curr Opin Immunol       Date:  1999-12       Impact factor: 7.486

7.  Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease.

Authors:  J P Hugot; M Chamaillard; H Zouali; S Lesage; J P Cézard; J Belaiche; S Almer; C Tysk; C A O'Morain; M Gassull; V Binder; Y Finkel; A Cortot; R Modigliani; P Laurent-Puig; C Gower-Rousseau; J Macry; J F Colombel; M Sahbatou; G Thomas
Journal:  Nature       Date:  2001-05-31       Impact factor: 49.962

8.  A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease.

Authors:  Y Ogura; D K Bonen; N Inohara; D L Nicolae; F F Chen; R Ramos; H Britton; T Moran; R Karaliuskas; R H Duerr; J P Achkar; S R Brant; T M Bayless; B S Kirschner; S B Hanauer; G Nuñez; J H Cho
Journal:  Nature       Date:  2001-05-31       Impact factor: 49.962

9.  Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitis.

Authors:  D Franchimont; S Vermeire; H El Housni; M Pierik; K Van Steen; T Gustot; E Quertinmont; M Abramowicz; A Van Gossum; J Devière; P Rutgeerts
Journal:  Gut       Date:  2004-07       Impact factor: 23.059

10.  Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis.

Authors:  Daniel Rachmilewitz; Kyoko Katakura; Fanny Karmeli; Tomoko Hayashi; Constantin Reinus; Bernard Rudensky; Shizuo Akira; Kiyoshi Takeda; Jongdae Lee; Kenji Takabayashi; Eyal Raz
Journal:  Gastroenterology       Date:  2004-02       Impact factor: 22.682

View more
  10 in total

Review 1.  IBD-what role do Proteobacteria play?

Authors:  Indrani Mukhopadhya; Richard Hansen; Emad M El-Omar; Georgina L Hold
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-02-21       Impact factor: 46.802

2.  Campylobacter jejuni disrupts protective Toll-like receptor 9 signaling in colonic epithelial cells and increases the severity of dextran sulfate sodium-induced colitis in mice.

Authors:  Jennifer R O'Hara; Troy D Feener; Carrie D Fischer; Andre G Buret
Journal:  Infect Immun       Date:  2012-02-06       Impact factor: 3.441

3.  Innate immunity and inflammatory bowel disease: a review of clinical evidence and future application.

Authors:  Kyoko Katakura; Hiroshi Watanabe; Hiromasa Ohira
Journal:  Clin J Gastroenterol       Date:  2013-11-22

4.  Expression and implication of toll-like receptors TLR2, TLR4 and TLR9 in colonic mucosa of patients with ulcerative colitis.

Authors:  Yan Tan; Kai-Fang Zou; Wei Qian; Sheng Chen; Xiao-Hua Hou
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-10-16

5.  Campylobacter jejuni increases flagellar expression and adhesion of noninvasive Escherichia coli: effects on enterocytic Toll-like receptor 4 and CXCL-8 expression.

Authors:  Kristen L Reti; Lisa D Tymensen; Shevaun P Davis; Matthias W Amrein; Andre G Buret
Journal:  Infect Immun       Date:  2015-09-14       Impact factor: 3.441

Review 6.  Genetic update on inflammatory factors in ulcerative colitis: Review of the current literature.

Authors:  Patricia Sarlos; Erzsebet Kovesdi; Lili Magyari; Zsolt Banfai; Andras Szabo; Andras Javorhazy; Bela Melegh
Journal:  World J Gastrointest Pathophysiol       Date:  2014-08-15

Review 7.  Characteristics of Japanese inflammatory bowel disease susceptibility loci.

Authors:  Yoshiaki Arimura; Hiroyuki Isshiki; Kei Onodera; Kanna Nagaishi; Kentaro Yamashita; Tomoko Sonoda; Takayuki Matsumoto; Atsushi Takahashi; Masakazu Takazoe; Keiko Yamazaki; Michiaki Kubo; Mineko Fujimiya; Kohzoh Imai; Yasuhisa Shinomura
Journal:  J Gastroenterol       Date:  2013-08-13       Impact factor: 7.527

8.  Toll-like receptor 9 (TLR9) polymorphism associated with symptomatic malaria: a cohort study.

Authors:  Ahmeddin H Omar; Michio Yasunami; Akiko Yamazaki; Hiroki Shibata; Michael F Ofori; Bartholomew D Akanmori; Mohammed Nasir Shuaibu; Mihoko Kikuchi; Kenji Hirayama
Journal:  Malar J       Date:  2012-05-17       Impact factor: 2.979

9.  Transcript levels of Toll-Like Receptors 5, 8 and 9 correlate with inflammatory activity in Ulcerative Colitis.

Authors:  Fausto Sánchez-Muñoz; Gabriela Fonseca-Camarillo; Marco A Villeda-Ramírez; Elizabeth Miranda-Pérez; Edgar J Mendivil; Rafael Barreto-Zúñiga; Misael Uribe; Rafael Bojalil; Aarón Domínguez-López; Jesús K Yamamoto-Furusho
Journal:  BMC Gastroenterol       Date:  2011-12-20       Impact factor: 3.067

10.  Involvement of Toll-like Receptor 9 polymorphism in cervical cancer development.

Authors:  Andrzej Roszak; Margarita Lianeri; Anna Sowińska; Pawel P Jagodziński
Journal:  Mol Biol Rep       Date:  2012-06-20       Impact factor: 2.316

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.